Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
1
×
biotech
bluebird bio
boston
1
×
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
1
×
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
romesh subramanian
1
×
san diego blog main
san francisco blog main
susanna high
vertex pharmaceuticals
What
ago
biotechs
considering
data
diseases
drug
dyne
early
expected
experimental
eyes
1
×
genetic
having
humans
ipo
ipos
long
1
×
medicines
muscle
rare
reach
therapeutics
worked
Language
unset
Current search:
eyes
×
long
×
" duchenne muscular dystrophy "
×
" romesh subramanian "
×
" avidity biosciences "
×
boston
×
@xconomy.com
4 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases